Correlation Between GM and BioNexus Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GM and BioNexus Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and BioNexus Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and BioNexus Gene Lab, you can compare the effects of market volatilities on GM and BioNexus Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of BioNexus Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and BioNexus Gene.

Diversification Opportunities for GM and BioNexus Gene

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GM and BioNexus is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and BioNexus Gene Lab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNexus Gene Lab and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with BioNexus Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNexus Gene Lab has no effect on the direction of GM i.e., GM and BioNexus Gene go up and down completely randomly.

Pair Corralation between GM and BioNexus Gene

Allowing for the 90-day total investment horizon General Motors is expected to generate 0.52 times more return on investment than BioNexus Gene. However, General Motors is 1.92 times less risky than BioNexus Gene. It trades about 0.32 of its potential returns per unit of risk. BioNexus Gene Lab is currently generating about -0.48 per unit of risk. If you would invest  5,273  in General Motors on August 28, 2024 and sell it today you would earn a total of  747.00  from holding General Motors or generate 14.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

General Motors  vs.  BioNexus Gene Lab

 Performance 
       Timeline  
General Motors 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in General Motors are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating primary indicators, GM displayed solid returns over the last few months and may actually be approaching a breakup point.
BioNexus Gene Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioNexus Gene Lab has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

GM and BioNexus Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GM and BioNexus Gene

The main advantage of trading using opposite GM and BioNexus Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, BioNexus Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNexus Gene will offset losses from the drop in BioNexus Gene's long position.
The idea behind General Motors and BioNexus Gene Lab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated